Feinberg School of Medicine, Northwestern University, Chicago, IL, 16 Children's Hospital Colorado, Aurora, CO, 17 Univeristy of Colorado, School of Medicine and Children's Hospital Colorado, Aurora, CO. RATIONALE: Eosinophilic esophagitis (EoE), a chronic allergic disease, lacks sensitive and specific peripheral biomarkers. We hypothesized that concentrations of EoE-related biomarkers captured using a 1-hour minimally invasive Esophageal String Test (EST) would correlate with mucosal eosinophil counts and tissueconcentrations of the same biomarkers. We aimed to determine if a 1-hour EST accurately distinguishes active from inactive EoE. METHODS: In a prospective, multi-site study, children and adults (ages 7-55yrs) undergoing a clinically indicated esophagogastroduodenoscopy performed an EST with an esophageal dwell time of 1-hour. Subjects were divided into 4 groups: 1) active EoE, 2) inactive (treated) EoE, 3) GERD and 4) normal esophageal mucosa. Eosinophil-associated proteins were compared between EST effluents and esophageal biopsy extracts. Statistical modeling was performed to select biomarkers that best correlated with eosinophilic inflammation. RESULTS: 143 subjects (96 children, 47 adults) with active EoE (n562), inactive EoE (n537), GERD (n59) and normal esophagus (n535) completed the study; no serious adverse events were recorded. ESTcaptured eosinophil-associated proteins were significantly correlated with peak eosinophils/HPF, endoscopic visual scoring (EREFS), and the same proteins extracted from mucosal biopsies. Statistical modeling, using combined eotaxin-3 and MBP-1 concentrations, led to the development of EoE scores that distinguished between subjects with active EoE compared to inactive EoE in subjects with an EoE diagnosis, and compared to subjects with inactive EoE, GERD or normal esophagi. CONCLUSIONS: The 1-hour EST can be used to accurately distinguish active from inactive disease in children and adults with EoE and facilitate monitoring of EoE disease activity in a safe, minimally invasive fashion. The present trial assessed whether a 4-food elimination diet (4-FED), in combination with proton pump inhibitor (PPI) treatment, is superior to PPI monotherapy in children with eosinophilic esophagitis (EoE). METHODS: After a baseline gastroscopy, patients with histologically proven EoE (> _15 eosinophils per high power field; HPF) were randomized to omeprazole 1mg/kg twice daily (max. dose 20mg b.i.d.) plus a 4-FED (cow's milk, soy, egg, wheat) vs omeprazole monotherapy. A second gastroscopy was performed after 8-12 weeks. Complete mucosal remission was defined as eosinophils <5/HPF, and partial remission as <10/HPF on repeat biopsy. RESULTS: Of 64 patients (median age 9.1 yrs) with EoE, 32 were randomized to PPI+4-FED, and 32 to PPI only. There was a higher rate of non-completers in the diet group (5/32 vs 1/32; NS). At baseline, median eosinophil counts were similar between groups (PPI 44. On per-protocol analysis, at least partial remission (<10 eosinophils/ HPF) was significantly more likely for PPI+4-FED vs PPI (88% vs 45%; p50.002), with borderline significance on intention-to-treat analysis (PPI+4-FED 69% vs PPI 44%; p50.054). CONCLUSIONS: This is the first randomized clinical trial demonstrating that a 4-FED combined with PPI is significantly more effective than PPI monotherapy in children with EoE.
